Shah Capital Management

recently disclosed that they own 13.5% of Vitamin Shoppe, Inc (NYSE:VSI) in a Schedule 13G disclosure that was filed with the Securities and Exchange Commission on Monday, November 20th. The investor owns 3,114,510 shares of the stock valued at $12,769,491. The reporting parties listed on the disclosure included Shah Capital Management, Inc (Scm), Shah Capital Opportunity Fund LP and Himanshu H Shah. The disclosure is available through Edgar at this link.

Several other hedge funds and other institutional investors have also modified their holdings of VSI. GMT Capital Corp acquired a new stake in shares of Vitamin Shoppe in the third quarter valued at about $3,423,000. Canada Pension Plan Investment Board increased its position in Vitamin Shoppe by 175.5% during the third quarter. Canada Pension Plan Investment Board now owns 652,600 shares of the specialty retailer’s stock worth $3,491,000 after purchasing an additional 415,700 shares during the last quarter. FMR LLC increased its position in Vitamin Shoppe by 32.4% during the second quarter. FMR LLC now owns 1,254,690 shares of the specialty retailer’s stock worth $14,617,000 after purchasing an additional 307,050 shares during the last quarter. Vanguard Group Inc. increased its position in Vitamin Shoppe by 14.8% during the first quarter. Vanguard Group Inc. now owns 2,186,549 shares of the specialty retailer’s stock worth $44,059,000 after purchasing an additional 282,598 shares during the last quarter. Finally, Systematic Financial Management LP increased its position in Vitamin Shoppe by 94.9% during the third quarter. Systematic Financial Management LP now owns 217,345 shares of the specialty retailer’s stock worth $1,163,000 after purchasing an additional 105,855 shares during the last quarter. Institutional investors and hedge funds own 85.35% of the company’s stock.

Vitamin Shoppe, Inc (NYSE:VSI) traded down $0.10 during midday trading on Monday, hitting $4.10. 838,459 shares of the stock traded hands, compared to its average volume of 516,135. The company has a current ratio of 2.07, a quick ratio of 0.32 and a debt-to-equity ratio of 0.59. Vitamin Shoppe, Inc has a twelve month low of $2.95 and a twelve month high of $26.35. The stock has a market capitalization of $100.71, a price-to-earnings ratio of 4.52 and a beta of 0.74.

Vitamin Shoppe (NYSE:VSI) last posted its quarterly earnings data on Wednesday, November 8th. The specialty retailer reported ($0.03) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.17 by ($0.20). Vitamin Shoppe had a negative net margin of 20.27% and a positive return on equity of 6.17%. The business had revenue of $288.20 million during the quarter, compared to analysts’ expectations of $297.61 million. During the same period in the previous year, the business posted $0.50 EPS. The company’s revenue for the quarter was down 8.5% compared to the same quarter last year. analysts forecast that Vitamin Shoppe, Inc will post 0.44 EPS for the current fiscal year.

In other Vitamin Shoppe news, Director John D. Bowlin acquired 40,000 shares of the stock in a transaction dated Friday, August 25th. The stock was acquired at an average price of $5.50 per share, with a total value of $220,000.00. Following the completion of the purchase, the director now owns 56,028 shares in the company, valued at approximately $308,154. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 1.07% of the company’s stock.

Several equities research analysts recently issued reports on VSI shares. BidaskClub cut shares of Vitamin Shoppe from a “hold” rating to a “sell” rating in a research report on Thursday, July 27th. Barclays PLC cut their price objective on shares of Vitamin Shoppe from $13.00 to $6.00 and set an “equal weight” rating for the company in a research report on Thursday, August 10th. Deutsche Bank AG restated a “hold” rating and set a $7.00 price objective (down from $14.00) on shares of Vitamin Shoppe in a research report on Thursday, August 10th. Goldman Sachs Group, Inc. (The) restated a “sell” rating and set a $6.00 price objective (down from $13.00) on shares of Vitamin Shoppe in a research report on Thursday, August 10th. Finally, Morgan Stanley set a $8.00 price objective on shares of Vitamin Shoppe and gave the stock a “hold” rating in a research report on Thursday, August 10th. Four equities research analysts have rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $5.00.

TRADEMARK VIOLATION WARNING: “13.5% Stake of Vitamin Shoppe, Inc (VSI) Held by Shah Capital Management” was originally reported by Daily Political and is owned by of Daily Political. If you are viewing this article on another publication, it was stolen and republished in violation of US and international trademark and copyright laws. The correct version of this article can be viewed at https://www.dailypolitical.com/2017/11/20/13-5-stake-of-vitamin-shoppe-inc-vsi-held-by-shah-capital-management.html.

About Vitamin Shoppe

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Want to see what other hedge funds are holding VSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vitamin Shoppe, Inc (NYSE:VSI).

Institutional Ownership by Quarter for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with MarketBeat.com's FREE daily email newsletter.